Technology ❯ Artificial Intelligence ❯ Healthcare Technology

Data Analytics

Clinical Decision Support Oncology Insights Biopharma Data Profiling Wearable Technology Incentive Modeling Clinical Applications Palantir Technologies

Tempus AI Agrees to Buy Personalis for $1.5 Billion

The stock-heavy offer would fold Personalis' NeXT Personal MRD test into Tempus' AI oncology platform pending shareholder and regulatory approval.

Mayo Clinic and Microsoft Announce Joint Frontier AI Model for Healthcare

Tempus AI and USC Launch Collaboration to Integrate AI in Precision Medicine

Gilead Expands Tempus Partnership for Enterprise Access to AI Oncology Platform

Function Raises $298 Million at $2.5 Billion Valuation, Launches Medical Intelligence Lab